Home > Press > Liquidia Technologies Retains Top Industry Talent to Lead Manufacturing Efforts
![]() |
Abstract:
Company Appoints Dr. Thomas Templeman, Senior Vice President
Liquidia Technologies Inc. today announced it has appointed Dr. Thomas Templeman as the company's Senior Vice President, Integrated Supply Chain. Liquidia is a leader in the development of rationally designed nanoparticles for delivery of small molecule and biological agents to enable breakthroughs in vaccines, inhaled therapeutics, and siRNA-based therapeutics.
"We are very pleased to welcome Dr. Templeman to Liquidia as we continue to expand and strengthen our capabilities in manufacturing," said Neal Fowler, CEO of Liquidia. "Dr. Templeman brings to Liquidia a diverse array of clinical and commercial manufacturing experience. He also has extensive knowledge in regulatory compliance and shares our passion for bringing safer and more effective therapies to market."
Dr. Templeman comes to Liquidia from Centocor Biologics, an operating company of Johnson & Johnson and manufacturing site that supports the Centocor family of biologic products. As General Manager, Dr. Templeman was responsible for establishing, managing, and updating regulated production facilities, including the implementation of operational and quality control systems.
"This is a very exciting opportunity for me, as the future of medicine will be defined by the availability of highly targeted therapies that provide greater safety and efficacy for patients," said Dr. Templeman. "Liquidia is clearly a leader in the field of nanoparticle-based therapies and I am honored to have the opportunity to help advance the company towards a new phase of product development."
Following his Postdoctoral Fellowship in Harvard University's Department of Cellular and Developmental Biology in 1989, Dr. Templeman gained extensive experience in R&D and manufacturing processes at Vysis, Imagenetics, Gene-Trak, Ortho Clinical Diagnostics and most recently at Centocor Biologics. Dr. Templeman's areas of expertise include the management of technical operations and the development, scale-up, and improvement of R&D processes to production output levels.
####
About Liquidia Technologies Inc.
Liquidia Technologies Inc. is a privately-held nanotechnology company that designs, develops, and manufactures precisely engineered particles and films for a wide variety of life and materials science applications. Within life sciences, Liquidia is focused on the development of rationally designed nanoparticles for various therapeutic applications including inhaled therapeutics, vaccines, and siRNA delivery. Materials science applications include nanoscale patterned optical films for use in display technologies and photovoltaic devices. The company was founded in 2004 on the discoveries of Professor Joseph DeSimone and colleagues at the University of North Carolina, Chapel Hill and is located in Research Triangle Park, North Carolina.
For more information, please click here
Contacts:
Liquidia Technologies
Elle Pishny, 919-328-4361
Copyright © Business Wire 2009
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Display technology/LEDs/SS Lighting/OLEDs
Efficient and stable hybrid perovskite-organic light-emitting diodes with external quantum efficiency exceeding 40 per cent July 5th, 2024
New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024
News and information
New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024
Single atoms show their true color July 5th, 2024
New method cracked for high-capacity, secure quantum communication July 5th, 2024
Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024
Nanomedicine
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024
Announcements
New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024
Single atoms show their true color July 5th, 2024
New method cracked for high-capacity, secure quantum communication July 5th, 2024
Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024
Appointments/Promotions/New hires/Resignations/Deaths
Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021
JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021
The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020
Solar/Photovoltaic
Development of zinc oxide nanopagoda array photoelectrode: photoelectrochemical water-splitting hydrogen production January 12th, 2024
Shedding light on unique conduction mechanisms in a new type of perovskite oxide November 17th, 2023
Inverted perovskite solar cell breaks 25% efficiency record: Researchers improve cell efficiency using a combination of molecules to address different November 17th, 2023
Charged “molecular beasts” the basis for new compounds: Researchers at Leipzig University use “aggressive” fragments of molecular ions for chemical synthesis November 3rd, 2023
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |